Keywords: biota, transfers, rsv, accord, astrazeneca, australian, drugmaker

Biota transfers RSV accord to AstraZeneca

Article | 01 September 2008

Print This

Australian drugmaker Biota says that its 2005 collaboration and license agreement with MedImmune has been assigned to the US firm's parent ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in